Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
hCA VB-IN-1
Cat. No.:
OB0425LY-165
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
hCA VB-IN-1 is a class of compounds that target carbonic anhydrase, which plays a key role in many physiological processes, including pH homeostasis and carbon dioxide excretion.
Synonyms:
hCA VB-IN-1; hCA VB-IN1; hCA VB IN1
Formula:
C9H13N3O4S
Formula Weight:
259.28
Specification
Target:
Carbonic anhydrase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
hCA VB-IN-1 can be used to study glaucoma, metabolic acidosis, and obesity-related tumors.
